Uridine is a Targetable Metabolic Dependency in Acute Lymphoblastic Leukemia |
Board of Trustees of the Leland Stanford Junior University / Kara Davis, D.O. |
R Accelerated Award Grants |
2024 |
California |
Understanding the role of CDK8 in protein synthesis for treating MYC-driven medulloblastoma |
University of Colorado Denver / Dong Wang, PhD |
Young Investigator Grants |
2024 |
Colorado |
The influence of the raphe nucleus and serotonin on progression of diffuse intrinsic pontine glioma |
Stanford University / Richard Drexler, MD/PhD |
Young Investigator Grants |
2024 |
California |
IGFBPL1 Peptide-Centric Chimeric Antigen Receptor Autologous T Cells for Relapsed HLA-A*02 Neuroblastoma and Medulloblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2024 |
Pennsylvania |
Uncovering new approaches to target FOXR2 in pediatric cancers |
Children’s Hospital Los Angeles / Jessica Tsai, MD/PhD |
'A' Award Grants |
2024 |
California |
Targeting Novel Inflammatory Signaling Pathways in Juvenile Myelomonocytic Leukemia |
Indiana University / Santhosh Kumar Pasupuleti, PhD |
'A' Award Grants |
2024 |
Indiana |
Development of allogeneic off-the-shelf gamma delta T cell product for pediatric AML |
Baylor College of Medicine / Norihiro Watanabe, PhD |
Innovation Grants |
2024 |
Texas |
DMG: From SWI/SNF’s role in cholesterol biosynthesis to new therapeutic opportunities |
Board of Trustees of the Leland Stanford Junior University / Capucine Van Rechem, PhD |
Innovation Grants |
2024 |
California |
Unraveling the Mechanisms of Inherited Predisposition to Childhood Leukemia |
Boston Children’s Hospital / Vijay Sankaran, MD/PhD |
Innovation Grants |
2024 |
Massachusetts |
Pathological Condensates and Transcription Dysregulation in Rhabdomyosarcoma at Single-Molecule Resolution |
California Institute of Technology / Shasha Chong, PhD |
Innovation Grants |
2024 |
California |